Benzinga Bulls and Bears: Alphabet, Micron, Nike
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Stocks · News reference
How Does Corteva, Vylor Stand After Spin-off?
Corteva expects net sales to reach $8.4 billion-$8.7 billion by 2029, while Vylor targets $11.2 billion-$11.9 billion in revenue.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stock Market Today: S&P 500, Dow Jones Futures Gain as September Jobs Report Misses Expectations— Nike, Synaptics, Corteva in Focus (UPDATED)
U.S. stock futures advanced on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's higher close.
Nike, Corteva, Mattel, Accenture and Coherent: Why These 5 Stocks Are on Investors' Radars Today
NKE, CTVA, MAT, ACN, COHR were among the stocks seen trending on Thursday, Oct. 1, 2026.
RBC Capital Initiates Coverage On Vylor with Outperform Rating, Announces Price Target of $85
This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Analysts initiated coverage: VYLR Outperform/$85, LBRX Buy/$68, ELVN Overweight/$70, SAIL Sector Weight, and AVLN Outperform/$60.
Vylor shares are trading higher after the company was added to the S&P 500. Also, Morgan Stanley and BMO Capital initiated coverage on the stock.